ストックスクリーナーアプリを入手
32.35
4.57%
1.2868
前日終値:
$31.06
開ける：
$31
24時間の取引高:
103.59K
Relative Volume:
0.56
時価総額：
$460.98M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.71%
1か月 パフォーマンス:
+45.39%
6か月 パフォーマンス:
+91.40%
1年 パフォーマンス:
-50.79%
1日の値動き範囲:
$30.99
$33.06
1週間の範囲:
$27.22
$35.47
52週間の値動き範囲:
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
NGNE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
32.30 | 443.29M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.90 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.19 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.06 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.21 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.00 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-17 | 開始されました | Craig Hallum | Buy |
| 2025-05-16 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | 開始されました | BMO Capital Markets | Outperform |
| 2024-06-11 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-29 | 開始されました | Leerink Partners | Outperform |
| 2024-03-21 | 開始されました | William Blair | Outperform |
| 2024-01-08 | 開始されました | H.C. Wainwright | Buy |
| 2024-01-05 | 開始されました | Stifel | Buy |
| 2024-01-04 | 開始されました | TD Cowen | Outperform |
すべてを表示
Neurogene Inc (NGNE) 最新ニュース
Volume spikes in Neurogene Inc. stock – what they mean2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com
Statistical indicators supporting Neurogene Inc.’s strengthJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
How to use a screener to detect Neurogene Inc. breakoutsMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com
Using AI based signals to follow Neurogene Inc.2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Will Neurogene Inc. (UU8) stock profit from automation wave2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
Why Neurogene Inc. stock is popular among millennialsWeekly Volume Report & Daily Price Action Insights - newser.com
Risk adjusted return profile for Neurogene Inc. analyzed2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Is Neurogene Inc. (UU8) stock supported by strong fundamentalsProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Neurogene Inc. stock a buy on dipsWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com
Why Neurogene Inc. (UU8) stock could be top winnerQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
Tools to monitor Neurogene Inc. recovery probabilityTrade Exit Summary & Consistent Growth Stock Picks - newser.com
Applying big data sentiment scoring on Neurogene Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Is Neurogene Inc. (UU8) stock among top earnings playsDip Buying & Safe Swing Trade Setups - newser.com
Can Neurogene Inc. (UU8) stock sustain institutional flowsQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Why Neurogene Inc. stock could outperform in 2025July 2025 Recap & High Conviction Buy Zone Picks - newser.com
Will Neurogene Inc. stock outperform growth indexesEarnings Growth Summary & Verified Momentum Watchlists - newser.com
Why Neurogene Inc. stock remains a top recommendationWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Signal strength of Neurogene Inc. stock in tech scanners2025 Volume Leaders & Free Verified High Yield Trade Plans - newser.com
Does Neurogene Inc. qualify in momentum factor screeningBond Market & AI Based Buy/Sell Signal Reports - newser.com
Why Neurogene Inc. stock remains undervaluedPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Will Neurogene Inc. (UU8) stock keep high P E multiplesPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Is Neurogene Inc. (UU8) stock a buy before new product rollout - newser.com
Price action breakdown for Neurogene Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
Why Neurogene Inc. (UU8) stock could break out in 20252025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Combining price and volume data for Neurogene Inc.July 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Neurogene Inc. $NGNE Shares Bought by Jennison Associates LLC - MarketBeat
Neurogene Inc (NGNE) 財務データ
Neurogene Inc (NGNE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.13%
0.49%
大文字化:
|
ボリューム (24 時間):